The Skin Cancer Foundation Comments on FDA Approval of Bavencio (Avelumab) for the Treatment of Merkel Cell Carcinoma - (March 29, 2017) - On March 23, 2017, the US Food and Drug Administration (FDA) approved Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with Merkel cell carcinoma, a rare, aggressive skin cancer.
The Skin Cancer Foundation Hosts Annual Member Reception in Orlando, Florida - (March 15, 2017) - The Skin Cancer Foundation hosted its annual Member Reception on March 3 at the Castle Hotel in Orlando, Florida, during the American Academy of Dermatology (AAD) Annual Meeting.
The Skin Cancer Foundation Response: Repeal of the Tanning Tax - (March 9, 2017) - The Skin Cancer Foundation strongly urges Congress to maintain this tax, which deters people from engaging in deadly tanning behaviors, and ultimately saves lives.
- The Skin Cancer Foundation Shares Three Ways to Lower Your Skin Cancer Risk in 2017– (January 3, 2017) - The beginning of a new year is typically when people assess their health and vow to improve their well-being. Resolving to take better care of your skin is a great place to start: after all, it is the body’s largest organ.
Press Releases from Recent Years